Dorie Apollonio, PhD, MPP

Title(s)Professor, Clinical Pharmacy
SchoolSchool of Pharmacy
Address530 Parnassus Avenue, #365
San Francisco CA 94143
Phone415-502-1942
ORCID ORCID Icon0000-0003-4694-0826 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of California, San FranciscoAmerican Legacy Foundation Fellow
    University of California, BerkeleyPhD
    Harvard University, Cambridge, MAMPP
    Macalester College, St. Paul, MNBA
    University of California, San Francisco, CA08/2021Diversity, Equity, and Inclusion Champion Training

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Postdoctoral Training in Tobacco Control
    NIH/NIDA T32DA057216Jul 1, 2023 - Jun 30, 2028
    Role: Multiple Principal Investigator
    Improving pharmacy-based tobacco cessation services in California’s Central Valley
    California Tobacco-Related Disease Research Program T33IR6471Jul 1, 2023 - Jun 30, 2026
    Role: Principal Investigator
    Addressing disparities in tobacco-related diseases by understanding the tobacco industry strategies
    NIH/NCI R01CA268491Aug 1, 2022 - Jul 31, 2027
    Role: Co-Investigator
    Characterizing online tobacco product marketing
    US Food and Drug Administration Tobacco Centers of Regulatory Science U54CA180890 (pilot)Jan 1, 2022 - Dec 31, 2022
    Role: Principal Investigator
    California cannabis poisonings under Proposition 64
    California Department of Cannabis Control RG-1603070583-553Sep 1, 2021 - Aug 31, 2023
    Role: Principal Investigator
    Effect of local tobacco flavor bans on consumption
    US Food and Drug Administration Tobacco Centers of Regulatory Science U54CA180890 (pilot)Jan 1, 2021 - Dec 31, 2021
    Role: Principal Investigator
    Effect of minimum floor price laws on tobacco consumption
    California Tobacco-Related Disease Research Program 31KT-1894Jul 1, 2020 - Jun 30, 2023
    Role: Co-Investigator
    Linking local variation in marijuana and opioid policies to health outcomes
    NIH R21DA046051Feb 1, 2019 - Jan 31, 2021
    Role: Principal Investigator
    Effects of California’s 2016 tobacco policies on initiation, use, & quitting
    California Tobacco-Related Disease Research Program 26IR-0014Jul 1, 2017 - Jun 30, 2019
    Role: PI
    Measuring combined tobacco, e-cigarette, and marijuana use in California
    California Tobacco-Related Disease Research Program 25IR-0025Nov 1, 2016 - Jun 30, 2019
    Role: Co-PI
    San Francisco Cancer Initiative (SF-CAN)
    UCSF Helen Diller Family Comprehensive Cancer Center Jul 1, 2016 - Jun 30, 2019
    Role: Co-investigator
    Uses of evidence in health policy
    UCSF Research Allocation Program Jul 1, 2015 - Dec 1, 2016
    Role: PI
    State and local policies addressing the use and sale of non-cigarette tobacco products
    NIH/NCI U01 CA 154240Oct 1, 2014 - Sep 3, 2015
    Role: Co-investigator
    Partnership to Advance Breast Cancer Research
    California Breast Cancer Research Program Jan 1, 2014 - Dec 31, 2014
    Role: Co-investigator on subaward
    Translating Research into Systemic Interventions for Tobacco Cessation
    NIH K07CA140236Sep 13, 2011 - Aug 31, 2016
    Role: Principal Investigator
    Creating systemic tobacco control interventions in marginalized populations
    American Cancer Society A114962Jul 1, 2010 - Dec 31, 2011
    Role: PI
    Description: Relinquished in Year 2 due to receipt of competing award
    Effect of Tobacco Advocacy at the State Level
    NIH/NIDA R01DA043950Jul 1, 1994 - Jun 30, 2021
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications
    Collapse Collaboration Interests
    Collapse Academic Senate

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reported exposures to derived cannabis products in California before and after the 2018 federal reclassification of hemp. Int J Drug Policy. 2024 Feb; 124:104313. Madan K, Schmidt S, Chami RF, Ho R, Lewis JC, Apollonio DE. PMID: 38194724.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    2. Descriptive cross-sectional survey of tobacco and cannabis restrictions on state and local film incentives in the USA. Tob Control. 2023 Nov 21. Wakefield TD, Guillory J, Ling P, Apollonio DE. PMID: 37989585.
      View in: PubMed   Mentions:    Fields:    
    3. Exposures to Bleach, Peroxide, Disinfectants, Antimalarials, and Ivermectin Reported to the California Poison Control System Before and During the COVID-19 Pandemic, 2015-2021. Public Health Rep. 2024 Jan-Feb; 139(1):112-119. Ghai A, Sabour E, Salonga R, Ho R, Apollonio DE. PMID: 37933467; PMCID: PMC10905766.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    4. Retail chain pharmacy opioid dispensing practices from 1997 to 2020: A content analysis of internal industry documents. Drug Alcohol Depend Rep. 2023 Dec; 9:100199. Chiu C, Wong A, Chhen J, Roderos AAJ, Apollonio DE. PMID: 38089554; PMCID: PMC10713840.
      View in: PubMed   Mentions:
    5. Pharmacist furnishing of hormonal contraception in California's Central Valley. J Am Pharm Assoc (2003). 2024 Jan-Feb; 64(1):226-234.e2. Azad A, Su J, Nguyen M, Ly M, Wu I, Tracy D, Song A, Apollonio DE. PMID: 37595885.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Cannabis industry campaign expenditures in Colorado, 2005-2021. Int J Drug Policy. 2023 09; 119:104156. Rotering T, Bialous S, Apollonio D. PMID: 37557020.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    7. Alignment in local approaches to alcohol and cannabis control policy: A case study of California cities and counties. Int J Drug Policy. 2023 09; 119:104114. Matthay EC, Mousli L, Apollonio DE, Schmidt LA. PMID: 37441979; PMCID: PMC10530325.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    8. Evaluation of a Pharmacist-Linked Smoking Cessation Intervention for Adults Experiencing Homelessness. Subst Use Misuse. 2023; 58(12):1519-1527. De Los Reyes G, Ng A, Valencia Chavez J, Apollonio DE, Kroon L, Lee P, Vijayaraghavan M. PMID: 37401115.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    9. Issues arising from the study design, conduct, and promotion of clinical trials funded by opioid manufacturers: a review of internal pharmaceutical industry documents. Evidence & Policy. 2023; (in press). Gac B, Yakubi H, Apollonio DE.
    10. Trends in concomitant and single opioid and benzodiazepine exposures reported to the California Poison Control System following the Centers for Disease Control and Prevention release of opioid guidelines in 2016. Clin Toxicol (Phila). 2023 04; 61(4):305-311. Chu E, Cocos G, Lee HJ, Go J, Lewis J, Apollonio DE. PMID: 36988441.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    11. Clearing cannabis criminal records: A survey of criminal record expungement availability and accessibility among US States and Washington DC that decriminalized or legalized cannabis. Int J Drug Policy. 2023 04; 114:103983. Wakefield T, Bialous S, Apollonio DE. PMID: 36863286.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    12. A review of policies on the involuntary use of psychotropic medications among persons experiencing incarceration in the United States. Health Justice. 2023 Feb 18; 11(1):9. Orta J, Barton C, Ilao P, Apollonio DE. PMID: 36807842; PMCID: PMC9938563.
      View in: PubMed   Mentions:
    13. Industry strategies to market opioids to children and women in the USA: a content analysis of internal industry documents from 1999 to 2017 released in State of Oklahoma v. Purdue Pharma, L.P. et al. BMJ Open. 2022 11 02; 12(11):e052636. Yakubi H, Gac B, Apollonio DE. PMID: 36323465; PMCID: PMC9639061.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. An observational study of the extent of naloxone furnishing in California Central Valley community pharmacies. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):566-573. Banawis M, Mah G, Mohsin R, Pobre J, Tracy D, Song AV, Apollonio DE. PMID: 36476261.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Marketing Antipsychotics to Correctional Facilities: A Review of Pharmaceutical Industry Documents. J Correct Health Care. 2022 10; 28(5):325-328. Apollonio DE. PMID: 36190495; PMCID: PMC9835282.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Equity in Coverage of Local Cannabis Control Policies in California, 2020‒2021. Am J Public Health. 2022 11; 112(11):1640-1650. Matthay EC, Mousli LM, Fu C, Zhang S, Ponicki WR, Gruenewald P, Apollonio DE, Schmidt LA. PMID: 36075009; PMCID: PMC9558199.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimalsPHPublic Health
    17. The Opioid Industry Documents Archive: A Living Digital Repository. Am J Public Health. 2022 08; 112(8):1126-1129. Caleb Alexander G, Mix LA, Choudhury S, Taketa R, Tomori C, Mooghali M, Fan A, Mars S, Ciccarone D, Patton M, Apollonio DE, Schmidt L, Steinman MA, Greene J, Ling PM, Seymour AK, Glantz S, Tasker K. PMID: 35830677; PMCID: PMC9342819.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    18. Content Analysis of the Corporate Social Responsibility Practices of 9 Major Cannabis Companies in Canada and the US. JAMA Netw Open. 2022 08 01; 5(8):e2228088. Wakefield T, Glantz SA, Apollonio DE. PMID: 35997980; PMCID: PMC9399867.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimals
    19. Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al. J Health Polit Policy Law. 2022 08 01; 47(4):453-472. Yakubi H, Gac B, Apollonio DE. PMID: 35044464.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    20. A Spatiotemporal Analysis of the Association of California City and County Cannabis Policies with Cannabis Outlet Densities. Epidemiology. 2022 09 01; 33(5):715-725. Matthay EC, Mousli L, Ponicki WR, Glymour MM, Apollonio DE, Schmidt LA, Gruenewald P. PMID: 35944153; PMCID: PMC9345518.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    21. A Retrospective Global Assessment of Factors Associated With COVID-19 Policies and Health Outcomes. Front Public Health. 2022; 10:843445. Choi AJ, Hean AC, Lee JK, Tran ND, Lin TK, Apollonio DE. PMID: 35615034; PMCID: PMC9125067.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    22. Cannabis use prevalence among Baby Boomers before and after implementation of recreational retail sales in California. Subst Abuse Treat Prev Policy. 2022 03 05; 17(1):17. Carlson Z, Pham S, El-Sokkary J, Apollonio DE. PMID: 35248117; PMCID: PMC8898516.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    23. A community-based tobacco cessation program for individuals experiencing homelessness. Addict Behav. 2022 06; 129:107282. Hartman-Filson M, Chen J, Lee P, Phan M, Apollonio DE, Kroon L, Donald F, Vijayaraghavan M. PMID: 35184003.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    24. Cannabis industry lobbying in the Colorado state legislature in fiscal years 2010-2021. Int J Drug Policy. 2022 04; 102:103585. Rotering T, Apollonio DE. PMID: 35085854; PMCID: PMC9632648.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimals
    25. Changes in California cannabis exposures following recreational legalization and the COVID-19 pandemic. Clin Toxicol (Phila). 2022 May; 60(5):632-638. Roth W, Tam M, Bi C, Kim J, Lewis J, Ho R, Apollonio DE. PMID: 34871128.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsPHPublic Health
    26. An observational survey assessing the extent of PrEP and PEP furnishing in San Francisco Bay Area pharmacies. J Am Pharm Assoc (2003). 2022 Jan-Feb; 62(1):370-377.e3. Bellman R, Mohebbi S, Nobahar N, Parizher J, Apollonio DE. PMID: 34429253.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic Health
    27. Retrospective review of nicotine exposures in California from 2012 to 2018 and analysis of the impacts of e-cigarette regulations. BMJ Open. 2021 03 02; 11(3):e043133. Driller G, Plasencia E, Apollonio DE. PMID: 33653751; PMCID: PMC7929887.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Associations between smoking trajectories, smoke-free laws and cigarette taxes in a longitudinal sample of youth and young adults. PLoS One. 2021; 16(2):e0246321. Apollonio DE, Dutra LM, Glantz SA. PMID: 33571218; PMCID: PMC7877665.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    29. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database Syst Rev. 2020 12 03; 12:CD013413. Vijayaraghavan M, Elser H, Frazer K, Lindson N, Apollonio D. PMID: 33284989; PMCID: PMC8130995.
      View in: PubMed   Mentions: 24     Fields:    Translation:Humans
    30. Implementing law into practice: hormonal contraceptive furnishing in San Francisco community pharmacies. Birth Control Pharmacist. 2020. Chen L, Lim J, Jeong A, Apollonio DE.
    31. Evaluation of naloxone furnishing community pharmacies in San Francisco. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):1050-1057.e1. Nguyen AM, Kearney TE, Apollonio DE. PMID: 32948461; PMCID: PMC7655520.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    32. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling. Clin Toxicol (Phila). 2021 Apr; 59(4):313-319. Wu A, Phan C, Nguyen KC, Quindoy M, Lewis J, Apollonio DE. PMID: 32840386; PMCID: PMC7996450.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    33. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):963-968.e2. Chen L, Lim J, Jeong A, Apollonio DE. PMID: 32800456; PMCID: PMC7423572.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    34. Cognitive performance effects of nicotine and industry affiliation: a systematic review. Subst Abuse. 2020; 14:1178221820926545. Pasetes SV, Ling PM, Apollonio DE. PMID: 32547048; PMCID: PMC7271274.
      View in: PubMed   Mentions: 1  
    35. Tobacco Industry Promotions and Pricing After Tax Increases: An Analysis of Internal Industry Documents. Nicotine Tob Res. 2020 05 26; 22(6):967-974. Apollonio DE, Glantz SA. PMID: 31058282; PMCID: PMC7249914.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansPHPublic Health
    36. Tobacco manufacturer lobbying to undercut minimum price laws: an analysis of internal industry documents. Tob Control. 2020 12; 29(e1):e10-e17. Apollonio DE, Glantz S. PMID: 31969381; PMCID: PMC7374022.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    37. Typologies of Party Finance Systems: A Comparative Study of How Countries Regulate Party Finance and Their Institutional Foundations. Elect Law J. 2019 Sep; 18(3):243-261. Wiltse DL, La Raja RJ, Apollonio DE. PMID: 34113217; PMCID: PMC8189065.
      View in: PubMed   Mentions:
    38. Interventions to reduce tobacco use in people experiencing homelessness. Cochrane Database of Systematic Reviews. 2019 Sep 2; (9). Vijayaraghavan VM, Elser EH, Apollonio AD. .
      View in: Publisher Site   Mentions:
    39. In defense of sugar: a critical analysis of rhetorical strategies used in The Sugar Association's award-winning 1976 public relations campaign. BMC Public Health. 2019 Aug 22; 19(1):1150. Kearns CE, Glantz SA, Apollonio DE. PMID: 31438900; PMCID: PMC6704551.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    40. Placement and sales of tobacco products and nicotine replacement therapy in tobacco-free and tobacco-selling pharmacies in Northern California: an observational study. BMJ Open. 2019 06 14; 9(6):e025603. Pimentel L, Apollonio DE. PMID: 31203236; PMCID: PMC6588971.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    41. A Review of Tobacco Policies on University of California Campuses. Calif J Health Promot. 2019 Jun; 17(1):24-30. Huey J, Apollonio DE. PMID: 34113223; PMCID: PMC8189569.
      View in: PubMed   Mentions:
    42. Prevalence and Correlates of Simultaneous and Separate 30-Day Use of Tobacco and Cannabis: Results from the California Adult Tobacco Survey. Subst Use Misuse. 2019; 54(10):1627-1632. Apollonio DE, Spetz J, Schmidt L, Jacobs L, Kaur M, Ramo D. PMID: 30973038; PMCID: PMC6768386.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    43. Engaging Adults Experiencing Homelessness in Smoking Cessation Through Large-Scale Community Service Events. Health Promot Pract. 2019 05; 20(3):325-327. Vijayaraghavan M, Apollonio DE. PMID: 30845844; PMCID: PMC7263353.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    44. Pharmacy students can improve access to quality medicines information by editing Wikipedia articles. BMC Med Educ. 2018 Nov 20; 18(1):265. Apollonio DE, Broyde K, Azzam A, De Guia M, Heilman J, Brock T. PMID: 30454046; PMCID: PMC6245851.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    45. 2018. Brock T, Apollonio DE. Paving the desire paths of health information needs: Teaching students to edit Wikipedia. BMC Series blog . View Publication.
    46. A content analysis of popular media reporting regarding increases in minimum ages of legal access for tobacco. BMC Public Health. 2018 Sep 17; 18(1):1129. Huey J, Apollonio DE. PMID: 30223799; PMCID: PMC6142702.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    47. Marketing with tobacco pack onserts: a qualitative analysis of tobacco industry documents. Tob Control. 2019 05; 28(3):274-281. Apollonio DE, Glantz SA. PMID: 29954860; PMCID: PMC6310666.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    48. The sugar industry's influence on policy. Science. 2018 05 04; 360(6388):501. Kearns C, Schmidt L, Apollonio D, Glantz S. PMID: 29724946; PMCID: PMC7289079.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    49. 2018. Tsoh J, Apollonio DE, Hall S, Vijayaraghvan M, Ramo DE, Ling P, Lempert LL, Glantz SA. FDA’s Nicotine Steering Committee should develop policies, regulations, and procedures that promote cessation and increase the use of proven therapies. US FDA Public Comment, Docket FDA-2018-N-0128.
    50. 2018. Apollonio DE, Glantz SA, Hall S, Lempert LL, St.Helen G, Tsoh J. The FDA should not adopt the nicotine “harm reduction” paradigm because doing so is likely to increase the amount of smoking-caused disease and death. US FDA Public Comment, Docket FDA-2017-N-6529.
    51. Sugar industry sponsorship of germ-free rodent studies linking sucrose to hyperlipidemia and cancer: An historical analysis of internal documents. PLoS Biol. 2017 Nov; 15(11):e2003460. Kearns CE, Apollonio D, Glantz SA. PMID: 29161267; PMCID: PMC5697802.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    52. Sustainable Pharmacy: Piloting a Session on Pharmaceuticals, Climate Change, and Sustainability within a U.S. Pharmacy Curriculum. Innov Pharm. 2017; 8(4). Gruenberg K, Apollonio D, MacDougall C, Brock T. PMID: 34123482; PMCID: PMC8191292.
      View in: PubMed   Mentions: 2  
    53. Tobacco Industry Research on Nicotine Replacement Therapy: "If Anyone Is Going to Take Away Our Business It Should Be Us". Am J Public Health. 2017 10; 107(10):1636-1642. Apollonio D, Glantz SA. PMID: 28817320; PMCID: PMC5599147.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    54. Evaluation of Tobacco Control Policies in San Francisco Homeless Housing Programs. Health Promot Pract. 2017 07; 18(4):571-580. Sung H, Apollonio DE. PMID: 28438037; PMCID: PMC5501332.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    55. Interpretation and use of evidence in state policymaking: a qualitative analysis. BMJ Open. 2017 02 20; 7(2):e012738. Apollonio DE, Bero LA. PMID: 28219958; PMCID: PMC5337675.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    56. Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev. 2016 11 23; 11:CD010274. Apollonio D, Philipps R, Bero L. PMID: 27878808; PMCID: PMC6464324.
      View in: PubMed   Mentions: 43     Fields:    Translation:Humans
    57. Realist review of policy intervention studies aimed at reducing exposures to environmental hazards in the United States. BMC Public Health. 2016 08 18; 16(1):822. Apollonio DE, Wolfe N, Bero LA. PMID: 27539238; PMCID: PMC4991102.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansPHPublic Health
    58. Challenges to generating evidence-informed policy and the role of systematic reviews and (perceived) conflicts of interest. J Commun Healthc. 2016; 9(2):135-141. Apollonio DE, Bero LA. PMID: 27721899; PMCID: PMC5055062.
      View in: PubMed   Mentions: 2     Fields:    
    59. Minimum Ages of Legal Access for Tobacco in the United States From 1863 to 2015. Am J Public Health. 2016 07; 106(7):1200-7. Apollonio DE, Glantz SA. PMID: 27196658; PMCID: PMC4902755.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    60. Organized Labor : Adaptive Strategies in Challenging Times. . 2016 Jan 1; 207-223. Apollonio AD. .
      View in: Publisher Site   Mentions:
    61. Overview of state policies requiring smoking cessation therapy in psychiatric hospitals and drug abuse treatment centers. Tob Induc Dis. 2015; 13:33. Krauth D, Apollonio DE. PMID: 26500471; PMCID: PMC4618524.
      View in: PubMed   Mentions: 8  
    62. Accuracy of popular media reporting on tobacco cessation therapy in substance abuse and mental health populations. BMJ Open. 2015 Mar 26; 5(3):e007169. Krauth D, Apollonio D. PMID: 25814498; PMCID: PMC4386271.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    63. Karma police: Prosecutorial strategies in obscenity cases and the broader cultural war. Syracuse Law and Civic Engagement Forum. 2015; (2):1-24. Lochner T, Apollonio DE.
    64. Tobacco industry efforts to influence policy: when interest groups face opposition. Interest Group Politics. 2015. Apollonio DE.
    65. Political advocacy in pharmacy: challenges and opportunities. Integr Pharm Res Pract. 2014; 3:89-95. Apollonio DE. PMID: 26301185; PMCID: PMC4540366.
      View in: PubMed   Mentions: 3  
    66. Karma Police: Prosecutorial Strategies in Obscenity Cases and the Broader Culture War. Syracuse Law Civ Engagem. 2014; 2. Lochner T, Apollonio D. PMID: 28090607; PMCID: PMC5231412.
      View in: PubMed   Mentions:
    67. Term limits and the tobacco industry. Soc Sci Med. 2014 Mar; 104:1-5. Apollonio DE, Glantz SA, Bero LA. PMID: 24581055; PMCID: PMC4071941.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Immigration and Prosecutorial Discretion. Calif J Politics Policy. 2013; 5(2):232-251. Apollonio D, Lochner T, Heddens M. PMID: 26146530; PMCID: PMC4486475.
      View in: PubMed   Mentions:
    69. Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Database Syst Rev. 2012 12 01; 12:1-10. Apollonio D, Philipps R, Bero L. PMID: 23833567; PMCID: PMC3698983.
      View in: PubMed   Mentions: 5     Fields:    
    70. The "We Card" program: tobacco industry "youth smoking prevention" as industry self-preservation. Am J Public Health. 2010 Jul; 100(7):1188-201. Apollonio DE, Malone RE. PMID: 20466965; PMCID: PMC2882417.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    71. Interest Groups. Developments in American Politics 6. 2010 Jan 1; 67-83. Apollonio AD. .
      View in: Publisher Site   Mentions:
    72. Evidence and argument in policymaking: development of workplace smoking legislation. BMC Public Health. 2009 Jun 17; 9:189. Apollonio DE, Bero LA. PMID: 19534777; PMCID: PMC2706247.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansPHPublic Health
    73. Turning negative into positive: public health mass media campaigns and negative advertising. Health Educ Res. 2009 Jun; 24(3):483-95. Apollonio DE, Malone RE. PMID: 18948569; PMCID: PMC2682642.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansPHPublic Health
    74. Wheat from chaff: Third-party monitoring and FEC enforcement actions. Regulation & Governance. 2008 Jun 1; 2(2):216-233. Lochner LT, Apollonio AD, Tatum TR. .
      View in: Publisher Site   Mentions:
    75. Access and lobbying: Looking beyond the corruption paradigm. Hastings Constitutional Law Quarterly. 2008; 1(36):13-50. Apollonio DE, Cain BE, Drutman L.
    76. Interest Groups, Lobbying, and Deception: The Tobacco Industry and Airline Smoking. Political Science Quarterly. 2007 Dec 1; 122(4):635-656. LOPIPERO LP, APOLLONIO AD, BERO BL. .
      View in: Publisher Site   Mentions:
    77. Participation and argument in legislative debate on statewide smoking restrictions. Health Res Policy Syst. 2007 Oct 22; 5:12. Apollonio DE, Lopipero P, Bero LA. PMID: 17953767; PMCID: PMC2174461.
      View in: PubMed   Mentions: 5     Fields:    
    78. Industry Front Groups: A Tobacco Case Study. Journal of Consumer Protection and Food Safety. 2007 Jul 30; 2(3):341-348. Apollonio AD, Bero BL. .
      View in: Publisher Site   Mentions:
    79. The creation of industry front groups: the tobacco industry and "get government off our back". Am J Public Health. 2007 Mar; 97(3):419-27. Apollonio DE, Bero LA. PMID: 17267719; PMCID: PMC1805008.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansPHPublic Health
    80. Industry front groups: A tobacco case study. Journal of consumer protection and food safety. 2007; 3(2):341-348. Apollonio DE, Bero LA.
    81. Term Limits, Campaign Contributions, and the Distribution of Power in State Legislatures. Legislative Studies Quarterly. 2006 May 1; 31(2):259-281. APOLLONIO AD, RAJA RR. .
      View in: Publisher Site   Mentions:
    82. Marketing to the marginalised: tobacco industry targeting of the homeless and mentally ill. Tob Control. 2005 Dec; 14(6):409-15. Apollonio DE, Malone RE. PMID: 16319365; PMCID: PMC1748120.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    83. Predictors of Interest Group Lobbying Decisions. The Forum. 2005 Nov 10; 3(3):0000102202154088841097. Apollonio AD. .
      View in: Publisher Site   Mentions:
    84. Interest Group Advocacy and the Power of "Magic Words". Election Law Journal Rules Politics and Policy. 2005 Sep 1; 4(3):178-190. Apollonio AD, Carne CM. .
      View in: Publisher Site   Mentions:
    85. Predictors of interest group lobbying decisions. The forum. 2005; 3(3):1-20. Apollonio DE.
    86. Who Gave Soft Money? The Effect of Interest Group Resources on Political Contributions. The Journal of Politics. 2004 Oct 4; 66(4):1134-1154. Apollonio AD, La Raja LR. .
      View in: Publisher Site   Mentions:
    87. The season of our discontent: Voters’ views on California elections. Public Policy Institute of California. 2004. Baldassare MA, Cain BE, Apollonio DE, Cohen JM.
    88. Who gave soft money? The effect of interest group resources on political contributions. The journal of politics. 2004; 4(66):1159-1179. Apollonio DE, La Raja RJ.
    89. Roper Social and Political Trends Data (1973-1994). 2000. Brady HE, Putnam RD, Campbell AL, Elms LE, Yonish S, Apollonio DE.
    90. Term limits affect legislators’ fund raising prowess. Public affairs report. 1999; 5(40). La Raja RJ, Apollonio DE.
    91. Trends in American political participation, 1973-1994. 1998. Brady HE, Apollonio DE, Elms LE.
    92. Hypopigmented sarcoidosis in the negro. Report of eight cases with ultrastructural observations. Br J Dermatol. 1977 Feb; 96(2):119-25. Clayton R, Breathnach A, Martin B, Feiwel M. PMID: 843445.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    93. Citrate synthase. Curr Top Cell Regul. 1976; 10:161-204. Weitzman PD, Danson MJ. PMID: 3389.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    94. Task delegation to physician extenders--some comparisons. Am J Public Health. 1976 Jan; 66(1):64-6. Glenn JK, Goldman J. PMID: 2022; PMCID: PMC1653348.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    95. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol. 1975 Sep 01; 24(17):1639-41. Schmoldt A, Benthe HF, Haberland G. PMID: 10.
      View in: PubMed   Mentions: 44     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Mentor Faculty

    Run Clinical Trials

    Work in Global Health Equity

    Offer Student Projects

    See more options in the Advanced Search tab

    Dorie's Networks
    Concepts (220)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (37)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.